Precious studies have suggested that FOXM1 overexpression was associated with tumor progression in patients with clear cell renal cell carcinoma [22], and FOXM1 silence could lead to liver cancer cell growth and a decline of CDK2 expression [23]. This evidence concerns the gene CDK2 and liver cancer.